Opioid Use Disorder
📧 Sign up to get email alerts when something new happens for Opioid Use Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Effects of Dynorphin 1-13 on Heroin Addiction - 1 [Phase 2]
Phase 2 clinical trial update assessing dynorphin 1-13 for heroin addiction; the study conducted at the University of Minnesota has complete…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14 [NA]
A completed clinical trial investigating the effects of combined sevoflurane and nitrous oxide inhalation in individuals with opioid use dis…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Effects of Combined Alcohol and Nitrous Oxide Intake - 15 [NA]
Clinical trial evaluating the effects of combined alcohol and nitrous oxide intake on individuals with opioid use disorder and other substan…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide - 13 [Phase 2]
This Phase 2 trial update investigates how a history of alcohol use affects responses to sevoflurane and nitrous oxide anesthesia in partici…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Subjective/Psychomotor/ Effects of Combined Alcohol & Nitrous Oxide - 16 [NA]
A completed clinical trial update examining the subjective and psychomotor effects of combined alcohol and nitrous oxide in individuals with…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Subjective Effects of Nitrous Oxide in Dental Patients - 17
This entry reports on a completed clinical trial evaluating the subjective effects of nitrous oxide in dental patients with opioid use disor…
-
FDA approval · 2015-05-14FDA Approved: NALTREXONE HYDROCHLORIDE — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for naltrexone hydrochloride by Accord Healthcare, Inc., authorizing a new generic product.
-
CLINICAL_TRIALS trial_result · 2015-04-17Clinical Trial Update: Assessment of Tramadol as a Treatment for Opioid Addiction [Phase 1, Phase 2]
The document reports the completion status of a Phase 1/2 clinical trial assessing tramadol for opioid use disorder.
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Directly Administered HIV Therapy in Methadone Clinics [Phase 2, Phase 3]
This update reports results from a Phase 2/3 trial evaluating directly administered HIV therapy delivered in methadone clinics.
-
CLINICAL_TRIALS withdrawal · 2015-04-15Clinical Trial Update: Directly Administered Antiretroviral Therapy (DAART) Among HIV-1infected Injecting Drug Users (IDUs) in Chennai, India [Phase 2, Phase 3]
A Phase 2/Phase 3 trial of directly administered antiretroviral therapy for HIV-1 infected injecting drug users in Chennai, India has been w…
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Improving Effective Contraceptive Use Among Opioid-maintained Women [Phase 1]
A completed Phase 1 clinical trial from the University of Vermont evaluating strategies to improve effective contraceptive use among women m…
-
FDA label_change · 2015-02-12FDA Approved: BUPRENORPHINE AND NALOXONE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for buprenorphine and naloxone from Actavis Pharma, Inc., resulting in a labeling change for the pro…
-
FDA approval · 2015-02-12FDA Approved: BUPRENORPHINE HCL AND NALOXONE HCL — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals' supplemental application for buprenorphine HCl and naloxone HCl.
-
FDA approval · 2015-02-12FDA Approved: ZUBSOLV — Supplemental Application (Orexo US, Inc.)
FDA approved a supplemental application for ZUBSOLV (buprenorphine hydrochloride and naloxone hydrochloride) by Orexo US, Inc.
-
FDA approval · 2015-02-12FDA Approved: BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for a generic buprenorphine hydrochloride and naloxone hydrochloride dihydrate product from Hikm…
-
FDA approval · 2015-02-12FDA Approved: BUPRENORPHINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma)
FDA approved a supplemental application for a generic buprenorphine hydrochloride product (ANDA 090622) from PAI Holdings/PAI Pharma.
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: The Comparison of Stress Response to Rapid Opioid Detoxification Applying Different Methods of Opioid Antagonism [NA]
A completed clinical trial from Vilnius University evaluating stress responses during rapid opioid detoxification using different opioid ant…
-
FDA approval · 2015-02-05FDA Approved: BUPRENORPHINE HCL AND NALOXONE HCL — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' supplemental ANDA for a generic buprenorphine HCl and naloxone HCl product for the treatment of opioid …
-
FDA approval · 2015-02-04FDA Approved: BUPRENORPHINE AND NALOXONE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved Actavis Pharma, Inc.'s supplemental application for Buprenorphine and Naloxone.
-
FDA approval · 2015-02-04FDA Approved: BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE DIHYDRATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Hikma's buprenorphine hydrochloride and naloxone hydrochloride dihydrate product for opioid use …
-
CLINICAL_TRIALS trial_result · 2015-02-03Clinical Trial Update: Using mHealth to Aid Opioid Medication Adherence Pilot Study
A pilot study evaluating the use of mobile health tools to support adherence to opioid medication treatment for opioid use disorder has comp…
-
CLINICAL_TRIALS trial_result · 2015-01-06Clinical Trial Update: Neuropsychoanalytic Treatment of Failed Back Surgery Syndrome-Opioid Dependence
A completed clinical trial evaluating a neuropsychoanalytic treatment approach for patients with failed back surgery syndrome and opioid dep…
-
FDA approval · 2014-12-13FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)
The FDA approved a supplemental application for methadone hydrochloride manufactured by SpecGx LLC. This approval confirms the continued sta…
-
FDA approval · 2014-12-13FDA Approved: METHADOSE DISPERSIBLE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for METHADOSE DISPERSIBLE, a dispersible methadone hydrochloride product filed by SpecGx LLC.
-
FDA approval · 2014-12-11FDA Approved: ZUBSOLV — Supplemental Application (Orexo US, Inc.)
FDA approved a supplemental application for ZUBSOLV (buprenorphine/naloxone) from Orexo US, Inc.